1 |
LENDERS J W,DUH Q Y,EISENHOFER G,et al.Pheochromocytoma and paraganglioma:an endocrine society clinical practice guideline[J]. J Clin Endocrinol Metab,2014,99(6):1915-1942.
|
2 |
EISENHOFER G,KOPIN I J,GOLDSTEIN D S.Catecholamine metabolism:a contemporary view with implications for physiology and medicine[J]. Pharmacol Rev,2004,56(3):331-349.
|
3 |
LENDERS J W,PACAK K,WALTHER M M,et al.Biochemical diagnosis of pheochromocytoma:which test is best[J]. JAMA,2002,287(11):1427-1434.
|
4 |
中华医学会内分泌学分会肾上腺学组. 嗜铬细胞瘤和副神经节瘤诊断治疗的专家共识[J]. 中华内分泌代谢杂志,2016,32(3):181-187.
|
5 |
PEITZSCH M,PREJBISZ A,KROIB M,et al.Analysis of plasma 3-methoxytyramine,normetanephrine and metanephrine by ultraperformance liquid chromatography-tandem mass spectrometry:utility for diagnosis of dopamine-producing metastatic phaeochromocytoma[J]. Ann Clin Biochem,2013,50(Pt 2):147-155.
|
6 |
陈方俊,吴炯,郭玮,等. 液相色谱-串联质谱检测血浆变肾上腺素和去甲变肾上腺素方法的建立[J]. 中华检验医学杂志,2015,38(9):605-608.
|
7 |
HUGHES N C,BAJAJ N,FAN J,et al.Assessing the matrix effects of hemolyzed samples in bioanalysis.[J]. Bioanalysis,2009,1(6):1057-1066.
|
8 |
国家药典委员会. 中华人民共和国药典:2015 年版[S].北京:中国医药科技出版社,2015.
|
9 |
European Medicines Agency,Committee for Medical Products for Human Use. Guideline on bioanalytical method validation[EB/OL].(2011-07-21)[2016-09-27].
|
10 |
Center for Drug Evaluation Research,US. Department of Health and Human Services,Food and Drug Administration. Draft guidance for industry:bioanalytical method validation (revised)[EB/OL].(2013-09-01)[2016-09-27].
|
11 |
DE RIJKE E,RUISCH B,BAKKER J,et al.LC-MS study to reduce ion suppression and to identify N-lactoylguanosine 5'-monophosphate in bonito: a new umami molecule?[J]. J Agric Food Chem,2007,55(16):6417-6423.
|
12 |
KUTER D J,MEHTA A,HOLLAK C E,et al.Miglustat therapy in type 1 Gaucher disease:clinical and safety outcomes in a multicenter retrospective cohort study[J]. Blood Cells Mol Dis,2013,51(2):116-124.
|
13 |
WU J,WIEGAND R,LORUSSO P,et al.A stable isotope-labeled internal standard is essential for correcting for the interindividual variability in the recovery of lapatinib from cancer patient plasma in quantitative LC-MS/MS analysis[J]. J Chromatogr B Analyt Technol Biomed Life Sci,2013,941:100-108.
|
14 |
INGELSE B,BARROSO B,GRAY N,et al.European Bioanalysis Forum:recommendation on dealing with hemolyzed and hyperlipidemic matrices[J]. Bioanalysis,2014,6(23):3113-3120.
|